Table 2.
Progression-free survival | Overall survival | |||
---|---|---|---|---|
HR (IC95%) | p-value | HR (IC95%) | p-value | |
EUA | 1.6 (0.6–2.2) | 0.645 | 2.2 (1.1–4.8) | 0.038 |
PS 2 | 2.1 (1.1–4.1) | 0.023 | 1.8 (0.7–4.4) | 0.198 |
Hg rate (continuous) | 0.8 (0.0–0.9) | 0.005 | 0.8 (0.6–1.1) | 0.174 |
Alb rate < 30 g/dl | 1.1 (0.5–2.3) | 0.908 | 0.5 (0.2–1.5) | 0.216 |
Kras mutation | 0.7 (0.4–1.2) | 0.181 | 0.4 (0.0–0.9) | 0.020 |
PDL1 ≥ 1% | 1.6 (0.6–4.2) | 0.295 | 3.0 (0.9–10.8) | 0.085 |
Citrulline < 20 μM | 3.8 (1.4–99.9) | 0.008 | 2.4 (0.6–10) | 0.222 |
Presence of Gemmatimonadaceae | 2.9 (0.9–9.2) | 0.073 | 16.4 (3.9–68.5) | < 0.001 |
HR hazard ratio, EUA early use of antibiotics, PS Performance status, Hg hemoglobin, Alb albumin